These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11585747)
21. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285 [TBL] [Abstract][Full Text] [Related]
22. P202: an interferon-inducible negative regulator of cell growth. Choubey D J Biol Regul Homeost Agents; 2000; 14(3):187-92. PubMed ID: 11037051 [No Abstract] [Full Text] [Related]
23. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain. Choubey D; Gutterman JU Biochem Biophys Res Commun; 1996 Apr; 221(2):396-401. PubMed ID: 8619867 [TBL] [Abstract][Full Text] [Related]
24. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1). Gutterman JU; Choubey D Cell Growth Differ; 1999 Feb; 10(2):93-100. PubMed ID: 10074903 [TBL] [Abstract][Full Text] [Related]
25. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
26. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice. Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501 [TBL] [Abstract][Full Text] [Related]
27. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. D'Souza S; Xin H; Walter S; Choubey D J Biol Chem; 2001 Jan; 276(1):298-305. PubMed ID: 11013253 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis. Xie YF; Sheng W; Xiang J; Zhang H; Ye Z; Yang J Cancer Biother Radiopharm; 2009 Apr; 24(2):261-9. PubMed ID: 19409049 [TBL] [Abstract][Full Text] [Related]
30. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Datta B; Min W; Burma S; Lengyel P Mol Cell Biol; 1998 Feb; 18(2):1074-83. PubMed ID: 9448005 [TBL] [Abstract][Full Text] [Related]
31. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer. Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845 [TBL] [Abstract][Full Text] [Related]
32. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533 [TBL] [Abstract][Full Text] [Related]
33. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model. Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378 [TBL] [Abstract][Full Text] [Related]
34. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198 [TBL] [Abstract][Full Text] [Related]
35. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes. Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model. Pan X; Sheng W; Zhu Q; Xie Y; Ye Z; Xiang J; Li D; Yang J Cancer Biother Radiopharm; 2008 Aug; 23(4):425-34. PubMed ID: 18771346 [TBL] [Abstract][Full Text] [Related]
37. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. Bloomston M; Shafii A; Zervos EE; Rosemurgy AS J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150 [TBL] [Abstract][Full Text] [Related]
38. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]. Liu JP; Yuan SZ; Zhang SN Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254 [TBL] [Abstract][Full Text] [Related]
39. Interferon-inducible p202 in the susceptibility to systemic lupus. Choubey D; Kotzin BL Front Biosci; 2002 May; 7():e252-62. PubMed ID: 11991834 [TBL] [Abstract][Full Text] [Related]
40. The murine p202 protein, an IFN-inducible modulator of transcription, is activated by the mitogen platelet-derived growth factor. Flati V; Frati L; Gulino A; Martinotti S; Toniato E J Interferon Cytokine Res; 2001 Feb; 21(2):99-103. PubMed ID: 11244574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]